+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Spatial OMICS Market, By Sample Type, By End Use, By Technology, By Product, By Workflow, Estimation & Forecast, 2018 - 2028

  • ID: 5511319
  • Report
  • October 2021
  • Region: Global
  • 179 Pages
  • Astute Analytica
UP TO OFF until Jul 31st 2022
The global spatial OMICS market held a market value of USD 230.2 million in 2020 and is estimated to reach USD 506.6 million by the year 2028. The market is anticipated to register a CAGR of 10.3% during the forecast period.



Spatial omics combines the molecular scrutiny with spatial data on the cell's localization in the interior of the tissue. Omics is a term brief for numerous diverse studies, such as epigenomics, genomics, transcriptomics, lipidomics proteomics, and metabolomics, among others.

The spatial OMICS market drivers include high applications as diagnostics tools, especially in oncology area. The growing cancer prevalace and incidence rates drive the market growth industrctly. Moreover, the high research and development carried out by private and public agencies boost the market growth. For instance, Ting Wu, a professor of genetics in the Blavatnik Institute at Harvard Medical School (HMS), created innovations that multiplex Oligopaint pipeline protocols and reagent methods, coupled with analysis techniques to generate a shorter time-to-result and more cost-effective approach to unswervingly envision the genome, spatially and in situ. Many aspects of this capability were highlighted in a 2020 publication in Nature Methods, thus generating a high level of awareness.

On the other hand, the lack of skilled technical professionals in developing, underdeveloped, and even few developing countries, curb the growth rate of this industry.

Growth Influencers:


Growing potential of spatial OMICS as a cancer diagnostic tool

Many emerging spatial OMICS technologies and advancements aid in the growth of the spatial OMICS market. For instance, spatial transcriptomics (ST) is an in situ capturing method, allowing quantification and visualization of transcriptomes in individual tissue sections. The application of spatial OMICS techniques in cancer diagnosis promises huge results for the near future.

Increasing adoption of spatial OMICS in drug discovery and development

Companies are utilizing spatial OMICS in understanding molecules during clinical trial studies. Drug discovery is a crucial phase in the overall clinical studies, and the utilization of spatial OMICS in drug development and discovery phases aids substantial growth currently and in the near future for the spatial OMICS market over the forecast period. For instance, Cancer Transcriptome Atlas by Nanostring is the first commercial GeoMx product that is enabled by readout using NGS. It includes over 1,800 genes and 100 pathways and provides a 20-fold increase in RNA coverage resulting in a high-resolution spatial view of cancer biology.

Segments Overview:


The global spatial OMICS market is segmented into sample type, end-use, technology, product, and workflow.

By Sample Type

  • FFPE
  • Fresh Frozen

The FFPE segment is held the largest market share of around 55% owing to the rise in examination, experimental research, and diagnostic progress. Moreover, the fresh frozen segment is projected to be the fastest growing owing to the steady demand rise.

By End Use

  • Academic & Translational Research Institutes
  • Pharmaceutical and Biotechnology Companies

The academic & translational research institutes segment held the largest share owing to a surge in government grants, funds for research, as well as the increased research focus on spatial genomics and other areas.

By Technology

  • Spatial Proteomics
  • Spatial Transcriptomics
  • Spatial Genomics

The spatial genomics segment is anticipated to grow the fastest with a CAGR of 12.3% due to the rise in chronic diseases. The launch of novel tools and instruments in this area drives the growth of this segment.

By Product
  • Instruments
  • Consumables
  • Software

The consumables segment is anticipated to hold a substantial share and cross USD 200 million market value by 2026. Mounting use of consumables, coupled with increasing applications of spatial transcriptomics in numerous fields, including drug discovery, drug development and biomarker identification drives the growth of this segment.

By Workflow
  • Sample Preparation
  • Instrumental Analysis
  • Data Analysis

The sample preparation segment is estimated to be the fastest growing segment owing to the rise in research studies, and clinical trial drug candidates. The market value of the segment is projected to hit USD 154 million in 2028.

Regional Overview


By region, the global spatial OMICS market is divided into Europe, North America, Asia Pacific, Middle East & Africa, and South America.

The Asia Pacific region is expected to grow the fastest at the rate of 11.4% in the spatial OMICS market owing to the high adoption rate of in situ sequencing techniques in research-focused countries, such as Japan, Australia, and India. Furthermore, the European region is anticipated to grow at a substantial rate owing to the rising awareness regarding spatial proteomics and transcriptomics area. Moreover, the Latin American and Middle Eastern & African region is also anticipated to grow at a considerable rate. The Middle East and Africa market value is projected to cross USD 10 million by 2027.

Competitive Landscape


Key players operating in the global spatial OMICS market include 10x Genomics, S2 Genomics, Inc., NanoString Technologies, Seven Bridges Genomics, PerkinElmer, Inc., Bio-Techne, Danaher Corporation, IonPath Inc., Millennium Science Pty Ltd, Akoya Biosciences, Inc., Fluidigm Corporation, Diagenode Diagnostics, Biognosys AG, Rebus Biosystems. Ultivue Inc, BioSpyder Technologies, and Bruker, among others.

Major 6 players in the market hold approximately 64% of the market share. These market players are investing in product launches, collaborations, mergers & acquisitions, and expansions to create a competitive edge in the market. For instance, in June 2020, NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, introduced new solutions to study the immune response in COVID-19 disease research.

The global spatial OMICS market report provides insights on the below pointers:

  • Market Penetration: Provides comprehensive information on the market offered by the prominent players
  • Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
  • Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
  • Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the global spatial OMICS market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
  • Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
  • Pricing Analysis: Pricing analysis of various metals and other components used in the manufacturing of spatial OMICS products
  • Manufacturing Cost Analysis: Cost-share of various components in spatial OMICS, cost analysis of spatial OMICS tools

The global Spatial OMICS market report answers questions such as:

  • What is the market size and forecast of the global spatial OMICS market?
  • What are the inhibiting factors and impact of COVID-19 on the global spatial OMICS market during the assessment period?
  • Which are the products/segments/applications/areas to invest in over the assessment period in the Global Spatial OMICS Market?
  • What is the competitive strategic window for opportunities in the global spatial OMICS market?
  • What are the technology trends and regulatory frameworks in the global spatial OMICS market?
  • What is the market share of the leading players in the global spatial OMICS market?
  • What modes and strategic moves are considered favorable for entering the global spatial OMICS market?
Frequently Asked Questions about the Global Spatial OMICS Market

What is the estimated value of the Global Spatial OMICS Market?

The Global Spatial OMICS Market was estimated to be valued at $230.2 million in 2020.

What is the growth rate of the Global Spatial OMICS Market?

The growth rate of the Global Spatial OMICS Market is 10.4%, with an estimated value of $506.6 million by 2028.

What is the forecasted size of the Global Spatial OMICS Market?

The Global Spatial OMICS Market is estimated to be worth $506.6 million by 2028.

Who are the key companies in the Global Spatial OMICS Market?

Key companies in the Global Spatial OMICS Market include 10x Genomics, S2 Genomics, Inc., NanoString Technologies, Seven Bridges Genomics, PerkinElmer, Inc., Bio, Techne, Danaher Corporation and Millennium Science Pty Ltd.

Table of Contents

Chapter 1. Research Framework
1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation
Chapter 2. Research Methodology
2.1 Qualitative Research
2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Spatial OMICS Market
Chapter 4. Global Spatial OMICS Market Overview
4.1. Drivers
4.1.1. Growing potential of spatial OMICS as a cancer diagnostic tools
4.1.2. Increasing adoption of spatial OMICS in drug discovery and development
4.2. Restraints
4.2.1. Lack of skilled professionals
4.3. Opportunities
4.3.1. Growing usage of spatial OMICS for biomarker identification
4.4. Impact of COVID-19 on Spatial OMICS Market
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
Chapter 5. Spatial OMICS Market Analysis, By Sample Type
5.1. Key Insights
5.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
5.2.1. FFPE
5.2.2. Fresh Frozen
Chapter 6. Spatial OMICS Market Analysis, By End-Use
6.1. Key Insights
6.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
6.2.1. Academic & Translational Research Institutes
6.2.2. Pharmaceutical and Biotechnology Companies
Chapter 7. Spatial OMICS Market Analysis, By Technology
7.1. Key Insights
7.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
7.2.1. Spatial Proteomics
7.2.2. Spatial Transcriptomics
7.2.3. Spatial Genomics
Chapter 8. Spatial OMICS Market Analysis, By Product
8.1. Key Insights
8.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
8.2.1. Instruments
8.2.2. Consumables
8.2.3. Software
Chapter 9. Spatial OMICS Market Analysis, By Workflow
9.1. Key Insights
9.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
9.2.1. Sample Preparation
9.2.2. Instrumental Analysis
9.2.3. Data Analysis
Chapter 10. Spatial OMICS Market Analysis, By Region/Country
10.1. Key Insights
10.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Germany
10.2.2.2. France
10.2.2.3. U.K.
10.2.2.4. Rest of Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. Rest of Asia Pacific
10.2.4. ROW
10.2.4.1. Latin America
10.2.4.2. Middle East and Africa
Chapter 11. North America Spatial OMICS Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
11.2.1. By Sample Type
11.2.2. By End-Use
11.2.3. By Technology
11.2.4. By Product
11.2.5. By Workflow
11.2.6. By Country
Chapter 12. Europe Spatial OMICS Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
12.2.1. By Sample Type
12.2.2. By End-Use
12.2.3. By Technology
12.2.4. By Product
12.2.5. By Workflow
12.2.6. By Country
Chapter 13. Asia Pacific Spatial OMICS Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
13.2.1. By Sample Type
13.2.2. By End-Use
13.2.3. By Technology
13.2.4. By Product
13.2.5. By Workflow
13.2.6. By Country
Chapter 14. MEA Spatial OMICS Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2018 - 2028 (US$ Mn)
14.2.1. By Sample Type
14.2.2. By End-Use
14.2.3. By Technology
14.2.4. By Product
14.2.5. By Workflow
14.2.6. By Country
Chapter 15. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
15.1. 10x Genomics
15.2. S2 Genomics, Inc.
15.3. NanoString Technologies
15.4. Seven Bridges Genomics
15.5. PerkinElmer, Inc.
15.6. Bio-Techne
15.7. Danaher Corporation
15.8. IonPath, Inc.
14.2.5. By Workflow
14.2.6. By Country
Chapter 15. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
15.1. 10x Genomics
15.2. S2 Genomics, Inc.
15.3. NanoString Technologies
15.4. Seven Bridges Genomics
15.5. PerkinElmer, Inc.
15.6. Bio-Techne
15.7. Danaher Corporation
15.8. IonPath, Inc.
15.9. Millennium Science Pty Ltd
15.10. Akoya Biosciences, Inc.
15.11. Fluidigm Corporation
15.12. Diagenode Diagnostics
15.13. Biognosys AG
15.14. Rebus Biosystems
15.15. Ultivue, Inc.
15.16. BioSpyder Technologies
15.17. Bruker

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 10x Genomics
  • S2 Genomics, Inc.
  • NanoString Technologies
  • Seven Bridges Genomics
  • PerkinElmer, Inc.
  • Bio-Techne
  • Danaher Corporation
  • IonPath, Inc.
  • Millennium Science Pty Ltd
  • Akoya Biosciences, Inc.
  • Fluidigm Corporation
  • Diagenode Diagnostics
  • Biognosys AG
  • Rebus Biosystems
  • Ultivue, Inc.
  • BioSpyder Technologies
  • Bruker